Edtech-HPV: A Community Approach Using Education and Technology to Increase HPV Vaccination

Memorial Sloan Kettering Cancer Center (MSK)

Status: Active, not recruiting

Conditions: Parents

Treatments: Behavioral: HPV Vaccine Education; Behavioral: Text Messaging Reminder

Study type: Interventional

Funder types: Other

Identifiers

NCT03209713

17-336

Details and patient eligibility

About

This study is a two-arm randomized controlled trial, implemented to assess the effectiveness of a community-based educational program with and without a text messaging reminder system, in increasing the rate of HPV vaccination completion among children of Mexican Americans.

The investigator's have extended the duration that participants are followed in assessing their child's uptake of the HPV vaccine to coincide with the COVID-19 related clinic closures and/or allow flexibility for participants who decide to delay their child's vaccination for fear of exposure to the COVID-19 infection.

A survey will also assess the participants concerns regarding the impact COVID-19 has had in their daily life, such as financial insecurity, food access, housing insecurity and among other most common concerns during this unprecedented time. Additional navigation, referrals and interviewer notes will also be captured. Participants may be called by site or MSK staff to complete study surveys and will be informed verbally or by a mailed letter.

Enrollment: 672 patients

Sex: All

Ages: 21 to 84 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Born in Mexico or born in U.S. but self-describes as Mexican-American
• Spanish is his or her primary language
• Has a minimum of one child between the ages of 11 and 17 who has not initiated or completed the HPV vaccine seriest (as per the age-recommended timeframe)
• Self-identifies as the child's main caregiver
• Currently owns a cell phone and uses text messaging services and is willing to accept text messages for this study
• 21 to 84 years old

Exclusion criteria

• Presence of a serious psychiatric or cognitive impairment likely to preclude meaningful informed consent and adherence to the protocol per the consenting professional's judgment.

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

672 participants in 2 patient groups

Parental Education

Active Comparator group

Description:

Participants will receive parental education on HPV vaccine and the vaccine's benefits.

Treatment:

Behavioral: HPV Vaccine Education

Parental Education + Text Messaging

Experimental group

Description:

Participants will receive parental education on HPV vaccine and the vaccine's benefits plus text messaging reminder.

Treatment:

Behavioral: Text Messaging Reminder

Behavioral: HPV Vaccine Education